Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007 Nov. 36(10):575-80. [QxMD MEDLINE Link].
Nico MM, Hammerschmidt M, Lourenço SV. Oral mucosal manifestations in some genodermatoses: correlation with cutaneous lesions. Eur J Dermatol. 2013 Sep-Oct. 23 (5):581-91. [QxMD MEDLINE Link].
Smith JF, Mincer HA, Hopkins KP, Bell J. Snuff-dipper's lesion. A cytological and pathological study in a large population. Arch Otolaryngol. 1970 Nov. 92 (5):450-6. [QxMD MEDLINE Link].
Donald PM, Renjith G, Arora A. Tobacco Pouch Keratosis in a young individual: A brief description. J Indian Soc Periodontol. 2017 May-Jun. 21 (3):249-251. [QxMD MEDLINE Link]. [Full Text].
Macey R, Walsh T, Brocklehurst P, Kerr AR, Liu JL, Lingen MW, et al. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev. 2015 May 29. 5:CD010276. [QxMD MEDLINE Link].
Sundberg J, Korytowska M, Holmberg E, et al. Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study. PLoS One. 2019. 14 (12):e0225682. [QxMD MEDLINE Link]. [Full Text].
Bagan JV, Jimenez Y, Sanchis JM, et al. Proliferative verrucous leukoplakia: high incidence of gingival squamous cell carcinoma. J Oral Pathol Med. 2003 Aug. 32(7):379-82. [QxMD MEDLINE Link].
Bagan JV, Murillo J, Poveda R, Gavalda C, Jimenez Y, Scully C. Proliferative verrucous leukoplakia: unusual locations of oral squamous cell carcinomas, and field cancerization as shown by the appearance of multiple OSCCs. Oral Oncol. 2004 Apr. 40(4):440-3. [QxMD MEDLINE Link].
Yogesh L, Aswath N. GSTM1 null polymorphism and palmar dermatoglypics in oral leukoplakia. Indian J Dent Res. 2021 Jan-Feb. 32 (1):69-73. [QxMD MEDLINE Link]. [Full Text].
Bouquot JE, Weiland LH, Kurland LT. Leukoplakia and carcinoma in situ synchronously associated with invasive oral/oropharyngeal carcinoma in Rochester, Minn., 1935-1984. Oral Surg Oral Med Oral Pathol. 1988 Feb. 65(2):199-207. [QxMD MEDLINE Link].
Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med. 2008 Jan. 37 (1):1-10. [QxMD MEDLINE Link].
Scully C. Rule for cancer diagnosis. Br Dent J. 2013 Sep. 215 (6):265-6. [QxMD MEDLINE Link].
Scully C, Sciubba JJ, Bagan JV. Oral mucosal precancer and cancer: A helpful discriminating clinical tool. Med Oral Patol Oral Cir Bucal. 2015 Sep 1. 20 (5):e587-90. [QxMD MEDLINE Link].
Fisher MA, Bouquot JE, Shelton BJ. Assessment of risk factors for oral leukoplakia in West Virginia. Community Dent Oral Epidemiol. 2005 Feb. 33(1):45-52. [QxMD MEDLINE Link].
El-Wajeh YA, Thornhill MH. Qat and its health effects. Br Dent J. 2009 Jan 10. 206(1):17-21. [QxMD MEDLINE Link].
Thomas SJ, Harris R, Ness AR, Taulo J, Maclennan R, Howes N, et al. Betel quid not containing tobacco and oral leukoplakia: a report on a cross-sectional study in Papua New Guinea and a meta-analysis of current evidence. Int J Cancer. Oct 2008. 123(8):1871-6.
Allen CL, Loudon J, Mascarenhas AK. Sanguinaria-related leukoplakia: epidemiologic and clinicopathologic features of a recently described entity. Gen Dent. 2001 Nov-Dec. 49(6):608-14. [QxMD MEDLINE Link].
Eversole LR, Eversole GM, Kopcik J. Sanguinaria-associated oral leukoplakia: comparison with other benign and dysplastic leukoplakic lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Apr. 89(4):455-64. [QxMD MEDLINE Link].
Poh CF, Zhang L, Lam WL, Zhang X, An D, Chau C, et al. A high frequency of allelic loss in oral verrucous lesions may explain malignant risk. Lab Invest. 2001 Apr. 81 (4):629-34. [QxMD MEDLINE Link].
Bremmer JF, Brakenhoff RH, Broeckaert MA, et al. Prognostic value of DNA ploidy status in patients with oral leukoplakia. Oral Oncol. 2011 Oct. 47(10):956-60. [QxMD MEDLINE Link].
Sudbo J, Kildal W, Risberg B, Koppang HS, Danielsen HE, Reith A. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med. 2001 Apr 26. 344(17):1270-8. [QxMD MEDLINE Link].
Zhang L, Poh CF, Williams M, Laronde DM, Berean K, Gardner PJ, et al. Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancer. Cancer Prev Res (Phila). 2012 Sep. 5 (9):1081-9. [QxMD MEDLINE Link].
Scully C. Challenges in predicting which oral mucosal potentially malignant disease will progress to neoplasia. Oral Dis. 2014 Jan. 20 (1):1-5. [QxMD MEDLINE Link].
Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med. 2015 Jul 20. [QxMD MEDLINE Link].
Jiang WW, Fujii H, Shirai T, Mega H, Takagi M. Accumulative increase of loss of heterozygosity from leukoplakia to foci of early cancerization in leukoplakia of the oral cavity. Cancer. 2001 Nov 1. 92(9):2349-56. [QxMD MEDLINE Link].
Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Oral premalignant lesions: is a biopsy reliable?. J Oral Pathol Med. 2007 May. 36(5):262-6. [QxMD MEDLINE Link].
Liu W, Zheng W, Xie J, Zhang B, Ma W, Chen X. Identification of genes related to carcinogenesis of oral leukoplakia by oligo cancer microarray analysis. Oncol Rep. 2011 Jul. 26(1):265-74. [QxMD MEDLINE Link].
Wagh A, Raval J, Aiyer RG, Amin S. Micronuclei in Exfoliated Oral Epithelial Cells in Tobacco Users and Controls with Various Oral Lesions: A Study from Gujarat, India. Indian J Otolaryngol Head Neck Surg. 2019 Mar. 71 (1):109-114. [QxMD MEDLINE Link]. [Full Text].
Chiesa F, Tradati N, Sala L, et al. Follow-up of oral leukoplakia after carbon dioxide laser surgery. Arch Otolaryngol Head Neck Surg. 1990 Feb. 116(2):177-80. [QxMD MEDLINE Link].
Donadini A, Maffei M, Cavallero A, Pentenero M, Malacarne D, Di Nallo E, et al. Oral cancer genesis and progression: DNA near-diploid aneuploidization and endoreduplication by high resolution flow cytometry. Cell Oncol. 2010. 32 (5-6):373-83. [QxMD MEDLINE Link].
Siebers TJ, Bergshoeff VE, Otte-Höller I, Kremer B, Speel EJ, van der Laak JA, et al. Chromosome instability predicts the progression of premalignant oral lesions. Oral Oncol. 2013 Dec. 49 (12):1121-8. [QxMD MEDLINE Link].
Graveland AP, Bremmer JF, de Maaker M, Brink A, Cobussen P, Zwart M, et al. Molecular screening of oral precancer. Oral Oncol. 2013 Dec. 49 (12):1129-35. [QxMD MEDLINE Link].
Abe M, Yamashita S, Mori Y, Abe T, Saijo H, Hoshi K, et al. High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes. BMC Cancer. 2016 Jun 3. 16:350. [QxMD MEDLINE Link].
Bhattacharyya S, Ray S, Saha D, et al. Chewing tobacco may act as a risk factor for dysplastic transformation of squamous cells in Oral leukoplakia- A cytochemistry based approach. Pathol Res Pract. 2021 Feb. 218:153287. [QxMD MEDLINE Link].
Garewal HS, Katz RV, Meyskens F, et al. Beta-carotene produces sustained remissions in patients with oral leukoplakia: results of a multicenter prospective trial. Arch Otolaryngol Head Neck Surg. 1999 Dec. 125(12):1305-10. [QxMD MEDLINE Link].
Brennan M, Migliorati CA, Lockhart PB, Wray D, Al-Hashimi I, Axell T. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Mar. 103 Suppl:S19.e1-12. [QxMD MEDLINE Link].
Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev. 2006 Oct 18. CD001829. [QxMD MEDLINE Link].
Chiesa F, Sala L, Costa L, et al. Excision of oral leukoplakias by CO2 laser on an out-patient basis: a useful procedure for prevention and early detection of oral carcinomas. Tumori. 1986 Jun 30. 72(3):307-12. [QxMD MEDLINE Link].
Sudbo J, Lippman SM, Lee JJ, et al. The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med. 2004 Apr 1. 350(14):1405-13. [QxMD MEDLINE Link].
Elad S, Epstein JB, von Bültzingslöwen I, Drucker S, Tzach R, Yarom N. Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents. Expert Opin Emerg Drugs. 2011 Mar. 16(1):183-202. [QxMD MEDLINE Link].